ONCOIMMUNIN

OncoImmunin, Inc. was founded by Dr. Akira Komoriya and Dr. Beverly Packard in 1994. The Company was an early participant in the University of Maryland's Technology Advancement Program, graduating to a full-fledged R&D company with state of the art facilities. It is currently located in Gaithersburg, Maryland, a region rich in small to medium size biotechnology companies. Thus far, OncoImmunin has been issued multiple U.S. and international patents with new applications as well CIP and PCT under review... Through consulting and hands-on activities, OncoImmunin's staff shares its expertise in assay development, particularly in the high throughput arena, to meet the specific needs of an ever increasing number of pharmaceutical companies... OncoImmunin's technology delivers oligonucleotides and peptides both in vivo and in vitro for therapeutic and assay applications.

Also known as: OncoImmunin, Inc.

Primary location: Gaithersburg United States